Selected research
Industry Research
Pharmaceutical and Medical Device Testing Industry Research Report 2026
Market perspective
The global Pharmaceutical and Medical Device Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical and Medical Device Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical and Medical Device Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical and Medical Device Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical and Medical Device Testing include SGS, Shimadzu, Charles River Laboratories, Eurofins, RCTS, Nelson Laboratories, DeviceLab, EAG Laboratories and EdgeOne Medical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical and Medical Device Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical and Medical Device Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical and Medical Device Testing Market by Company
SGS
Shimadzu
Charles River Laboratories
Eurofins
RCTS
Nelson Laboratories
DeviceLab
EAG Laboratories
EdgeOne Medical
Element
NAMSA
Pace Labs
Intertek
Associates of Cape Cod (ACC)
Tentamus
EKG Labs
MycoScience
GDMDT
Guangdong Lewwin
GTTC
PONY
Guangzhou Guobiao
CAS Testing Technical Services
Guangzhou General Pharmaceutical Research Institute
Guangdong Huawei Testing
Shanghai Ingeer
CIRS
Shanghai Fuda
Pharmaceutical and Medical Device Testing Segment by Type
Drug Testing
Medical Device Testing
Pharmaceutical and Medical Device Testing Segment by Application
Enterprise
Research Institution
College and University
Pharmaceutical and Medical Device Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical and Medical Device Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical and Medical Device Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical and Medical Device Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical and Medical Device Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Testing
- Medical Device Testing
Applications
- Enterprise
- Research Institution
- College and University
Companies covered
- SGS
- Shimadzu
- Charles River Laboratories
- Eurofins
- RCTS
- Nelson Laboratories
- DeviceLab
- EAG Laboratories
- EdgeOne Medical
- Element
- NAMSA
- Pace Labs
- Intertek
- Associates of Cape Cod (ACC)
- Tentamus
- EKG Labs
- MycoScience
- GDMDT
- Guangdong Lewwin
- GTTC
- PONY
- Guangzhou Guobiao
- CAS Testing Technical Services
- Guangzhou General Pharmaceutical Research Institute
- Guangdong Huawei Testing
- Shanghai Ingeer
- CIRS
- Shanghai Fuda
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical and Medical Device Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Drug Testing
- 2.2.3 Medical Device Testing
- 2.3 Pharmaceutical and Medical Device Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Enterprise
- 2.3.3 Research Institution
- 2.3.4 College and University
- 2.4 Assumptions and Limitations
3 Pharmaceutical and Medical Device Testing Breakdown Data by Type
- 3.1 Global Pharmaceutical and Medical Device Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical and Medical Device Testing Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical and Medical Device Testing Breakdown Data by Application
- 4.1 Global Pharmaceutical and Medical Device Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical and Medical Device Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical and Medical Device Testing Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical and Medical Device Testing Growth Trends by Region
- 5.2.1 Global Pharmaceutical and Medical Device Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical and Medical Device Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical and Medical Device Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical and Medical Device Testing Market Dynamics
- 5.3.1 Pharmaceutical and Medical Device Testing Industry Trends
- 5.3.2 Pharmaceutical and Medical Device Testing Market Drivers
- 5.3.3 Pharmaceutical and Medical Device Testing Market Challenges
- 5.3.4 Pharmaceutical and Medical Device Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical and Medical Device Testing Players by Revenue
- 6.1.1 Global Top Pharmaceutical and Medical Device Testing Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical and Medical Device Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical and Medical Device Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical and Medical Device Testing Head Office and Area Served
- 6.4 Global Pharmaceutical and Medical Device Testing Players, Product Type & Application
- 6.5 Global Pharmaceutical and Medical Device Testing Manufacturers Established Date
- 6.6 Global Pharmaceutical and Medical Device Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical and Medical Device Testing Market Size (2021-2032)
- 7.2 North America Pharmaceutical and Medical Device Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical and Medical Device Testing Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical and Medical Device Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical and Medical Device Testing Market Size (2021-2032)
- 8.2 Europe Pharmaceutical and Medical Device Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical and Medical Device Testing Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical and Medical Device Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical and Medical Device Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical and Medical Device Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical and Medical Device Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical and Medical Device Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical and Medical Device Testing Market Size (2021-2032)
- 10.2 South America Pharmaceutical and Medical Device Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical and Medical Device Testing Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical and Medical Device Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical and Medical Device Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical and Medical Device Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical and Medical Device Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical and Medical Device Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 SGS
- 12.1.1 SGS Company Information
- 12.1.2 SGS Business Overview
- 12.1.3 SGS Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.1.4 SGS Pharmaceutical and Medical Device Testing Product Portfolio
- 12.1.5 SGS Recent Developments
- 12.2 Shimadzu
- 12.2.1 Shimadzu Company Information
- 12.2.2 Shimadzu Business Overview
- 12.2.3 Shimadzu Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.2.4 Shimadzu Pharmaceutical and Medical Device Testing Product Portfolio
- 12.2.5 Shimadzu Recent Developments
- 12.3 Charles River Laboratories
- 12.3.1 Charles River Laboratories Company Information
- 12.3.2 Charles River Laboratories Business Overview
- 12.3.3 Charles River Laboratories Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.3.4 Charles River Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
- 12.3.5 Charles River Laboratories Recent Developments
- 12.4 Eurofins
- 12.4.1 Eurofins Company Information
- 12.4.2 Eurofins Business Overview
- 12.4.3 Eurofins Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.4.4 Eurofins Pharmaceutical and Medical Device Testing Product Portfolio
- 12.4.5 Eurofins Recent Developments
- 12.5 RCTS
- 12.5.1 RCTS Company Information
- 12.5.2 RCTS Business Overview
- 12.5.3 RCTS Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.5.4 RCTS Pharmaceutical and Medical Device Testing Product Portfolio
- 12.5.5 RCTS Recent Developments
- 12.6 Nelson Laboratories
- 12.6.1 Nelson Laboratories Company Information
- 12.6.2 Nelson Laboratories Business Overview
- 12.6.3 Nelson Laboratories Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.6.4 Nelson Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
- 12.6.5 Nelson Laboratories Recent Developments
- 12.7 DeviceLab
- 12.7.1 DeviceLab Company Information
- 12.7.2 DeviceLab Business Overview
- 12.7.3 DeviceLab Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.7.4 DeviceLab Pharmaceutical and Medical Device Testing Product Portfolio
- 12.7.5 DeviceLab Recent Developments
- 12.8 EAG Laboratories
- 12.8.1 EAG Laboratories Company Information
- 12.8.2 EAG Laboratories Business Overview
- 12.8.3 EAG Laboratories Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.8.4 EAG Laboratories Pharmaceutical and Medical Device Testing Product Portfolio
- 12.8.5 EAG Laboratories Recent Developments
- 12.9 EdgeOne Medical
- 12.9.1 EdgeOne Medical Company Information
- 12.9.2 EdgeOne Medical Business Overview
- 12.9.3 EdgeOne Medical Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.9.4 EdgeOne Medical Pharmaceutical and Medical Device Testing Product Portfolio
- 12.9.5 EdgeOne Medical Recent Developments
- 12.10 Element
- 12.10.1 Element Company Information
- 12.10.2 Element Business Overview
- 12.10.3 Element Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.10.4 Element Pharmaceutical and Medical Device Testing Product Portfolio
- 12.10.5 Element Recent Developments
- 12.11 NAMSA
- 12.11.1 NAMSA Company Information
- 12.11.2 NAMSA Business Overview
- 12.11.3 NAMSA Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.11.4 NAMSA Pharmaceutical and Medical Device Testing Product Portfolio
- 12.11.5 NAMSA Recent Developments
- 12.12 Pace Labs
- 12.12.1 Pace Labs Company Information
- 12.12.2 Pace Labs Business Overview
- 12.12.3 Pace Labs Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.12.4 Pace Labs Pharmaceutical and Medical Device Testing Product Portfolio
- 12.12.5 Pace Labs Recent Developments
- 12.13 Intertek
- 12.13.1 Intertek Company Information
- 12.13.2 Intertek Business Overview
- 12.13.3 Intertek Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.13.4 Intertek Pharmaceutical and Medical Device Testing Product Portfolio
- 12.13.5 Intertek Recent Developments
- 12.14 Associates of Cape Cod (ACC)
- 12.14.1 Associates of Cape Cod (ACC) Company Information
- 12.14.2 Associates of Cape Cod (ACC) Business Overview
- 12.14.3 Associates of Cape Cod (ACC) Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.14.4 Associates of Cape Cod (ACC) Pharmaceutical and Medical Device Testing Product Portfolio
- 12.14.5 Associates of Cape Cod (ACC) Recent Developments
- 12.15 Tentamus
- 12.15.1 Tentamus Company Information
- 12.15.2 Tentamus Business Overview
- 12.15.3 Tentamus Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.15.4 Tentamus Pharmaceutical and Medical Device Testing Product Portfolio
- 12.15.5 Tentamus Recent Developments
- 12.16 EKG Labs
- 12.16.1 EKG Labs Company Information
- 12.16.2 EKG Labs Business Overview
- 12.16.3 EKG Labs Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.16.4 EKG Labs Pharmaceutical and Medical Device Testing Product Portfolio
- 12.16.5 EKG Labs Recent Developments
- 12.17 MycoScience
- 12.17.1 MycoScience Company Information
- 12.17.2 MycoScience Business Overview
- 12.17.3 MycoScience Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.17.4 MycoScience Pharmaceutical and Medical Device Testing Product Portfolio
- 12.17.5 MycoScience Recent Developments
- 12.18 GDMDT
- 12.18.1 GDMDT Company Information
- 12.18.2 GDMDT Business Overview
- 12.18.3 GDMDT Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.18.4 GDMDT Pharmaceutical and Medical Device Testing Product Portfolio
- 12.18.5 GDMDT Recent Developments
- 12.19 Guangdong Lewwin
- 12.19.1 Guangdong Lewwin Company Information
- 12.19.2 Guangdong Lewwin Business Overview
- 12.19.3 Guangdong Lewwin Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.19.4 Guangdong Lewwin Pharmaceutical and Medical Device Testing Product Portfolio
- 12.19.5 Guangdong Lewwin Recent Developments
- 12.20 GTTC
- 12.20.1 GTTC Company Information
- 12.20.2 GTTC Business Overview
- 12.20.3 GTTC Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.20.4 GTTC Pharmaceutical and Medical Device Testing Product Portfolio
- 12.20.5 GTTC Recent Developments
- 12.21 PONY
- 12.21.1 PONY Company Information
- 12.21.2 PONY Business Overview
- 12.21.3 PONY Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.21.4 PONY Pharmaceutical and Medical Device Testing Product Portfolio
- 12.21.5 PONY Recent Developments
- 12.22 Guangzhou Guobiao
- 12.22.1 Guangzhou Guobiao Company Information
- 12.22.2 Guangzhou Guobiao Business Overview
- 12.22.3 Guangzhou Guobiao Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.22.4 Guangzhou Guobiao Pharmaceutical and Medical Device Testing Product Portfolio
- 12.22.5 Guangzhou Guobiao Recent Developments
- 12.23 CAS Testing Technical Services
- 12.23.1 CAS Testing Technical Services Company Information
- 12.23.2 CAS Testing Technical Services Business Overview
- 12.23.3 CAS Testing Technical Services Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.23.4 CAS Testing Technical Services Pharmaceutical and Medical Device Testing Product Portfolio
- 12.23.5 CAS Testing Technical Services Recent Developments
- 12.24 Guangzhou General Pharmaceutical Research Institute
- 12.24.1 Guangzhou General Pharmaceutical Research Institute Company Information
- 12.24.2 Guangzhou General Pharmaceutical Research Institute Business Overview
- 12.24.3 Guangzhou General Pharmaceutical Research Institute Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.24.4 Guangzhou General Pharmaceutical Research Institute Pharmaceutical and Medical Device Testing Product Portfolio
- 12.24.5 Guangzhou General Pharmaceutical Research Institute Recent Developments
- 12.25 Guangdong Huawei Testing
- 12.25.1 Guangdong Huawei Testing Company Information
- 12.25.2 Guangdong Huawei Testing Business Overview
- 12.25.3 Guangdong Huawei Testing Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.25.4 Guangdong Huawei Testing Pharmaceutical and Medical Device Testing Product Portfolio
- 12.25.5 Guangdong Huawei Testing Recent Developments
- 12.26 Shanghai Ingeer
- 12.26.1 Shanghai Ingeer Company Information
- 12.26.2 Shanghai Ingeer Business Overview
- 12.26.3 Shanghai Ingeer Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.26.4 Shanghai Ingeer Pharmaceutical and Medical Device Testing Product Portfolio
- 12.26.5 Shanghai Ingeer Recent Developments
- 12.27 CIRS
- 12.27.1 CIRS Company Information
- 12.27.2 CIRS Business Overview
- 12.27.3 CIRS Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.27.4 CIRS Pharmaceutical and Medical Device Testing Product Portfolio
- 12.27.5 CIRS Recent Developments
- 12.28 Shanghai Fuda
- 12.28.1 Shanghai Fuda Company Information
- 12.28.2 Shanghai Fuda Business Overview
- 12.28.3 Shanghai Fuda Revenue in Pharmaceutical and Medical Device Testing Business (2021-2026)
- 12.28.4 Shanghai Fuda Pharmaceutical and Medical Device Testing Product Portfolio
- 12.28.5 Shanghai Fuda Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst